...
首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >False-positive reverse transcriptase polymerase chain reaction screening for SARS-CoV-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications
【24h】

False-positive reverse transcriptase polymerase chain reaction screening for SARS-CoV-2 in the setting of urgent head and neck surgery and otolaryngologic emergencies during the pandemic: Clinical implications

机译:假阳性逆转录酶聚合酶链反应筛选SARS-COV-2在大流行期间紧急头部和颈部手术和耳鼻喉科诊断突出事件中的筛选:临床意义

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background No reports describe falsepositive reverse transcriptase polymerase chain reaction (RT-PCR) for novel coronavirus in preoperative screening. Methods Preoperative patients had one or two nasopharyngeal swabs, depending on low or high risk of viral transmission. Positive tests were repeated. Results Forty-three of 52 patients required two or more preoperative tests. Four (9.3%) had discrepant results (positive/negative). One of these left the coronavirus disease (COVID) unit against medical advice despite an orbital abscess, with unknown true disease status. The remaining 3 of 42 (7.1%) had negative repeat RT-PCR. Although ultimately considered falsepositives, one was sent to a COVID unit postoperatively and two had urgent surgery delayed. Assuming negative repeat RT-PCR, clear chest imaging, and lack of subsequent symptoms represent the "gold standard," RT-PCR specificity was 0.97. Conclusions If false positives are suspected, we recommend computed tomography (CT) of the chest and repeat RT-PCR. Validated serum immunoglobulin testing may ultimately prove useful.
机译:背景技术在术前筛选中,没有报告描述了新型冠状病毒的虚假逆转录酶聚合酶链反应(RT-PCR)。方法术前患者有一个或两个鼻咽拭子,取决于病毒传播的低风险。重复阳性测试。结果43例52名患者中的两个或更多术前试验。四(9.3%)具有差异的结果(阳性/阴性)。其中之一留下了冠状病毒疾病(Covid)单位,尽管有眶脓肿,但具有未知的真实疾病状态。剩下的32例(7.1%)具有阴性重复RT-PCR。虽然最终被认为是虚假的姿势,但术后被送到了一个Covid单元,两者延迟了紧急手术。假设阴性重复RT-PCR,透明胸部成像,缺乏后续症状代表“黄金标准”,RT-PCR特异性为0.97。结论如果怀疑误报,我们建议胸部的层析成像(CT)并重复RT-PCR。验证的血清免疫球蛋白测试可能最终证明有用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号